Press-release for stocks related to for for astrazeneca plc

Prices are updated after-hours

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 1.86% -4.19% 3.6K

| 1.82% | O: 1.47% H: 1.16% C: -1.27%
AZN | News | $70.13 2.31% 2.24% 4.3M

| 3.71% | O: 3.34% H: 0.27% C: -0.62%
children approved treatment for

74%

26%

MTTR | News M | $4.8 175.86% 63.6% 71M

AGBA | $2.5 100.0% 56.6% 200M

MLEC | $2.47 76.43% 42.62% 78M

NUWE | $0.334 29.96% 40.99% 2.5M

EDBL | News | $6.26 66.49% 40.13% 16M

ATGL | $2.86 46.25% 32.8% 180K

VIVK | $1.43 33.65% 27.7% 530K

MNTS | $0.5 35.69% 26.3% 4.7M

SDIG A | $3.64 35.32% 26.0% 990K

PROK | $2.72 33.33% 24.58% 2.6M

Save your searches and get alerts when important news are released.